Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Matinas BioPharma Hldgs Q2 EPS $(0.03), Inline

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year.
byBenzinga Newsdesk
August 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With Rivian Automotive Stock?

By Erica Kollmann
January 18, 2:34 PM
Rivian announced the availability of its R1S electric SUV for leasing on Wednesday. The R1S can be leased for 36 months at approximately $1,169 per month. Rivian shares are trading below the stock's 50-day moving average of $19.01, and 18.87% of available shares are being sold short which may be adding to the price volatility.

RIVN